TBI-166 inhibits DlaT and LpdC, exhibiting synergistic effects with Bedaquiline and Pyrazinamide against Mycobacterium tuberculosis
Chennan Liu, L Zhang, Zimo Wang, Xi Li, Bin Wang, Yu Lu
This paper evaluates a three-drug regimen combining TBI-166, bedaquiline, and pyrazinamide against Mycobacterium tuberculosis, showing synergistic effects and metabolic disruption.
bioRxiv · May 20, 2026 · PreprintMicrobiology